192 related articles for article (PubMed ID: 30059454)
21. The association between endometriosis and survival outcomes of ovarian cancer: Evidence-based on a meta-analysis.
Yang B; Wang D; Chen H; Yang F
Niger J Clin Pract; 2015; 18(5):577-83. PubMed ID: 26096232
[TBL] [Abstract][Full Text] [Related]
22. Evidence for the Relationship Between Endometriosis and Epithelial Ovarian Cancer.
del Carmen MG
Obstet Gynecol Surv; 2015 Sep; 70(9):587-95. PubMed ID: 26403563
[TBL] [Abstract][Full Text] [Related]
23. Significance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Int J Gynecol Cancer; 2018 Jan; 28(1):11-18. PubMed ID: 28930811
[TBL] [Abstract][Full Text] [Related]
24. Does Endometriosis Hinder Successful Ovarian Debulking Surgery?
Sananpanichkul P; Muangtan S; Suknikhom W; Bhamarapravatana K; Suwannarurk K
Asian Pac J Cancer Prev; 2018 Feb; 19(2):509-512. PubMed ID: 29480993
[TBL] [Abstract][Full Text] [Related]
25. The clinical significance of the combined detection of serum Smac, HE4 and CA125 in endometriosis-associated ovarian cancer.
Xu XR; Wang X; Zhang H; Liu MY; Chen Q
Cancer Biomark; 2018 Feb; 21(2):471-477. PubMed ID: 29226858
[TBL] [Abstract][Full Text] [Related]
26. Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience.
Mangili G; Bergamini A; Taccagni G; Gentile C; Panina P; Viganò P; Candiani M
Gynecol Oncol; 2012 Sep; 126(3):403-7. PubMed ID: 22609111
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for endometriotic-cyst associated ovarian cancer: A case controlled study.
Udomsinkul P; Triratanachart S; Oranratanaphan S
Taiwan J Obstet Gynecol; 2020 Mar; 59(2):269-274. PubMed ID: 32127149
[TBL] [Abstract][Full Text] [Related]
28. [Epigenetic inactivation of SPOCK2 in the malignant transformation of ovarian endometriosis].
Ren F; Wang DB; Li T
Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):822-5. PubMed ID: 22333230
[TBL] [Abstract][Full Text] [Related]
29. Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/progesterone receptors.
Del Carmen MG; Smith Sehdev AE; Fader AN; Zahurak ML; Richardson M; Fruehauf JP; Montz FJ; Bristow RE
Cancer; 2003 Oct; 98(8):1658-63. PubMed ID: 14534882
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Immune Infiltrates in Ovarian Endometriosis and Endometriosis-Associated Ovarian Cancer: Relationship with Histological and Clinical Features.
Spagnolo E; Martinez A; Mascarós-Martínez A; Marí-Alexandre J; Carbonell M; González-Cantó E; Pena-Burgos EM; Mc Cormack BA; Tomás-Pérez S; Gilabert-Estellés J; López-Carrasco A; Hidalgo P; Ángeles MA; Redondo A; Gallego A; Hernández A
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569458
[TBL] [Abstract][Full Text] [Related]
31. Histopathology and ARID1A Expression in Endometriosis- Associated Ovarian Carcinoma (EAOC) Carcinogenesis Model with Endometrial Autoimplantation and DMBA Induction.
Wuyung PE; Rahadiati FB; Tjahjadi H; Salinah S; Kusmardi K; Kodariah R; Wiweko B
Asian Pac J Cancer Prev; 2021 Feb; 22(2):553-558. PubMed ID: 33639673
[TBL] [Abstract][Full Text] [Related]
32. The molecular signature of endometriosis-associated endometrioid ovarian cancer differs significantly from endometriosis-independent endometrioid ovarian cancer.
Banz C; Ungethuem U; Kuban RJ; Diedrich K; Lengyel E; Hornung D
Fertil Steril; 2010 Sep; 94(4):1212-1217. PubMed ID: 19643405
[TBL] [Abstract][Full Text] [Related]
33. Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; McKee B; Hoskins WJ; Barakat RR
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):79-85. PubMed ID: 12182977
[TBL] [Abstract][Full Text] [Related]
34. Understanding malignant transformation of endometriosis: imaging features with pathologic correlation.
Robinson KA; Menias CO; Chen L; Schiappacasse G; Shaaban AM; Caserta MP; Elsayes KM; VanBuren WM; Bolan CW
Abdom Radiol (NY); 2020 Jun; 45(6):1762-1775. PubMed ID: 30941451
[TBL] [Abstract][Full Text] [Related]
35. Aberrant expression of genes associated with stemness and cancer in endometria and endometrioma in a subset of women with endometriosis.
Ponandai-Srinivasan S; Andersson KL; Nister M; Saare M; Hassan HA; Varghese SJ; Peters M; Salumets A; Gemzell-Danielsson K; Lalitkumar PGL
Hum Reprod; 2018 Oct; 33(10):1924-1938. PubMed ID: 30020448
[TBL] [Abstract][Full Text] [Related]
36. Endometriosis-Associated Ovarian Cancer: Population Characteristics and Prognosis.
Barreta A; Sarian L; Ferracini AC; Eloy L; Brito ABC; de Angelo Andrade L; Derchain S
Int J Gynecol Cancer; 2018 Sep; 28(7):1251-1257. PubMed ID: 30142123
[TBL] [Abstract][Full Text] [Related]
37. Endometriosis does not confer improved prognosis in ovarian clear cell carcinoma: a retrospective study at a single institute.
Zhao T; Shao Y; Liu Y; Wang X; Guan L; Lu Y
J Ovarian Res; 2018 Jun; 11(1):53. PubMed ID: 29941051
[TBL] [Abstract][Full Text] [Related]
38. Derivation and validation of a nomogram based on clinical characteristics to diagnose endometriosis associated ovarian cancer preoperatively.
Xu T; Nie X; Zhang L; Meng H; Jiang Y; Wan Y; Cheng W
J Cancer Res Clin Oncol; 2024 Jan; 150(1):19. PubMed ID: 38243112
[TBL] [Abstract][Full Text] [Related]
39. The prognostic significance of stage I ovarian clear cell and endometrioid carcinomas arising from endometriotic cysts: is it a myth?
Ayhan A; Akilli H; Haberal N
Arch Gynecol Obstet; 2019 Jan; 299(1):217-222. PubMed ID: 30315413
[TBL] [Abstract][Full Text] [Related]
40. Prognostic importance of atypical endometriosis with architectural hyperplasia versus cytologic atypia in endometriosis-associated ovarian cancer.
Ñiguez Sevilla I; Machado Linde F; Marín Sánchez MDP; Arense JJ; Torroba A; Nieto Díaz A; Sánchez Ferrer ML
J Gynecol Oncol; 2019 Jul; 30(4):e63. PubMed ID: 31074246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
